Open and enrolling
A5394: Safety, Tolerability, and Impact of Oral TLR8 Agonist Selgantolimod on HBsAg
Treatment Category
Hepatitis
Open and enrolling
A5394: Safety, Tolerability, and Impact of Oral TLR8 Agonist Selgantolimod on HBsAg
Treatment Category